Breast Cancer News
Dr. Matthew J. Ellis named new director of Lester and Sue Smith Breast Center Jun 10, 2014 Dr. Matthew Ellis, a renowned clinician scientist in the area of genomics and molecular profiling of breast cancer, has been named as the new director of the Lester and Sue Smith Breast Center at Baylor.
Study profiles parents’ attitudes on genomic studies, data sharing and privacy Mar 11, 2014 Baylor researchers find parents are more concerned about the future risk to their child, when considering enrollment in genetic studies.
High throughput “viewing” identifies new regulator of estrogen receptor Jan 23, 2014 A high throughput microscopy technique enabled our researchers to identify a a highly amplified gene in many tumors, including breast, prostate and ovarian cancer.
Breast cell survival factor increases breast cancer risk after late pregnancy Dec 31, 2013 The mystery of why the risk of breast cancer goes up in women whose first pregnancies occur after the age of 35 may boil down to a single factor. according to Baylor researchers.
Clinical trial looks at new way to prevent hair loss with chemotherapy Oct 16, 2013 Baylor College of Medicine researchers are seeking volunteers to participate in a new study that will test the safety of a scalp cooling device to prevent hair loss associated with chemotherapy.
Baylor receives $960,000 plus in Komen breast cancer grants Aug 1, 2013 Four Baylor College of Medicine researchers received new grant funding from Susan G. Komen for the Cure to help advance breast cancer research.
Baylor College of Medicine’s breast care program for underserved recognized May 16, 2013 Baylor College of Medicine's The Lester and Sue Smith Breast Center and its medical director, Dr. Mothaffar Rimawi, will be honored at the Komen Houston Impact Awards Luncheon May 30.
Signature of circulating breast tumor cells that spread to the brain found Apr 10, 2013 BCM researchers find biomarkers of circulating breast tumor cells destined for the brain, insight into how disease spreads.
Certain breast cancer patients may benefit from combined HER-2 targeted treatment without chemotherapy Apr 8, 2013 BCM researchers find certain breast cancer patients may benefit from targeted therapy for tumors.
O'Malley receives five-year, $7.8 million Innovator Award from DOD Feb 13, 2013 The grant is one of no more than three such programs funded across the nation.